Expansion of Vγ9Vδ2 T Cells Is Triggered byFrancisella tularensis-Derived Phosphoantigens in Tularemia but Not after Tularemia Vaccination

ABSTRACT Tularemia is a disease caused by the facultative intracellular bacterium Francisella tularensis. Here we demonstrate that during the first weeks of infection, a significant increase in levels of Vγ9Vδ2 cells occurred in peripheral blood: in 13 patients analyzed 7 to 18 days after the onset of disease, these lymphocytes represented, on average, 30.5% of CD3+ cells and nearly 100% of γδ+ T cells. By contrast, after vaccination with the live vaccine strain (LVS) of F. tularensis, only a minor increase occurred. Eleven days after vaccination, γδ T cells represented an average of 6.7% and Vγ9Vδ2 cells represented an average of 5.3% of T cells, as in control subjects. Since derivatives of nonpeptidic pyrophosphorylated molecules, referred to as phosphoantigens, are powerful stimuli for Vγ9Vδ2 cells, this observation prompted an investigation of phosphoantigens in F. tularensis strains. The F. tularensis phosphoantigens triggered in vitro a proliferative response of human Vγ9Vδ2 peripheral blood leukocytes as well as a cytotoxic response and tumor necrosis factor release from a Vγ9Vδ2 T-cell clone. Quantitatively similar phosphoantigenic activity was detected in acellular extracts from two clinical isolates (FSC171 and Schu) and from LVS. Taken together, the chemical nature of the stimulus from the clinical isolates and the significant increase in levels of Vγ9Vδ2 cells in peripheral blood of tularemia patients indicate that phosphoantigens produced by virulent strains of F. tularensis trigger in vivo expansion of γδ T cells in tularemia.

[1]  M. Bonneville,et al.  A novel nucleotide‐containing antigen for human blood γδ T lymphocytes , 1996, European journal of immunology.

[2]  H. C. van der Heyde,et al.  Human gamma delta T cell subset-proliferative response to malarial antigen in vitro depends on CD4+ T cells or cytokines that signal through components of the IL-2R. , 1996, Journal of immunology.

[3]  M. Bonneville,et al.  Plasmodium falciparum stimuli for human gammadelta T cells are related to phosphorylated antigens of mycobacteria , 1996, Infection and immunity.

[4]  M. Bonneville,et al.  Stimulation of γδ T cells by phosphoantigens , 1996 .

[5]  M. Bonneville,et al.  The antituberculous Mycobacterium bovis BCG vaccine is an attenuated mycobacterial producer of phosphorylated nonpeptidic antigens for human gamma delta T cells , 1995, Infection and immunity.

[6]  G. De Libero,et al.  Human Vγ9‐Vδ2 cells are stimulated in a crossreactive fashion by a variety of phosphorylated metabolites , 1995 .

[7]  M. Bonneville,et al.  Early activation of human V gamma 9V delta 2 T cell broad cytotoxicity and TNF production by nonpeptidic mycobacterial ligands. , 1995, Journal of immunology.

[8]  B. Bloom,et al.  Natural and synthetic non-peptide antigens recognized by human γδ T cells , 1995, Nature.

[9]  W. Boom,et al.  CD4+ alpha beta T cell and gamma delta T cell responses to Mycobacterium tuberculosis. Similarities and differences in Ag recognition, cytotoxic effector function, and cytokine production. , 1995, Journal of immunology.

[10]  H. Band,et al.  V gamma 2V delta 2 TCR-dependent recognition of non-peptide antigens and Daudi cells analyzed by TCR gene transfer. , 1995, Journal of immunology.

[11]  S. Kishimoto,et al.  Increase of gamma/delta T cells in hospital workers who are in close contact with tuberculosis patients , 1994, Infection and immunity.

[12]  Y. Tanaka,et al.  Nonpeptide ligands for human gamma delta T cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[13]  B. Schoel,et al.  Phosphate is essential for stimulation of Vγ9Vδ2 T lymphocytes by mycobacterial low molecular weight ligand , 1994 .

[14]  M. Bonneville,et al.  Stimulation of human gamma delta T cells by nonpeptidic mycobacterial ligands. , 1994, Science.

[15]  S. Kaufmann,et al.  Phosphate is essential for stimulation of V gamma 9V delta 2 T lymphocytes by mycobacterial low molecular weight ligand. , 1994, European journal of immunology.

[16]  B. Balbi,et al.  T-Lymphocytes with γδ + Vδ2+ Antigen Receptors Are Present in Increased Proportions in a Fraction of Patients with Tuberculosis or with Sarcoidosis , 1993 .

[17]  B. Balbi,et al.  T-lymphocytes with gamma delta+ V delta 2+ antigen receptors are present in increased proportions in a fraction of patients with tuberculosis or with sarcoidosis. , 1993, The American review of respiratory disease.

[18]  N. Shijubo,et al.  [Phenotypic analysis in peripheral blood lymphocytes of patients with pulmonary tuberculosis]. , 1992, Kekkaku : [Tuberculosis].

[19]  A. Tärnvik,et al.  Various membrane proteins of Francisella tularensis induce interferon-gamma production in both CD4+ and CD8+ T cells of primed humans. , 1992, Immunology.

[20]  Takashi Ito,et al.  Increased Proportions of Peripheral Blood γδ T Cells in Patients with Pulmonary Tuberculosis , 1992 .

[21]  T. Sumida,et al.  Predominant expansion of V gamma 9/V delta 2 T cells in a tularemia patient , 1992, Infection and immunity.

[22]  J. Funada,et al.  Increased proportions of peripheral blood gamma delta T cells in patients with pulmonary tuberculosis. , 1992, Chest.

[23]  I. Fajac,et al.  Gamma/delta T-lymphocytes are not increased in number in granulomatous lesions of patients with tuberculosis or sarcoidosis. , 1991, The American review of respiratory disease.

[24]  A. Tärnvik,et al.  The T-cell-stimulating 17-kilodalton protein of Francisella tularensis LVS is a lipoprotein , 1991, Infection and immunity.

[25]  A. Tärnvik,et al.  Nucleotide sequence and T cell epitopes of a membrane protein of Francisella tularensis. , 1990, Journal of immunology.

[26]  A. Tärnvik,et al.  Several membrane polypeptides of the live vaccine strain Francisella tularensis LVS stimulate T cells from naturally infected individuals , 1990, Journal of clinical microbiology.

[27]  A. Tärnvik Nature of protective immunity to Francisella tularensis. , 1989, Reviews of infectious diseases.

[28]  J. Ilonen,et al.  A whole-blood lymphocyte stimulation test for the diagnosis of human tularemia. , 1984, The Journal of infectious diseases.

[29]  A. Tärnvik,et al.  Antigen from Francisella tularensis: nonidentity between determinants participating in cell-mediated and humoral reactions , 1984, Infection and immunity.

[30]  D. Burke Immunization against tularemia: analysis of the effectiveness of live Francisella tularensis vaccine in prevention of laboratory-acquired tularemia. , 1977, The Journal of infectious diseases.

[31]  Harold Vagtborg Use of nonhuman primates in drug evaluation : a symposium , 1968 .

[32]  R. E. Chamberlain,et al.  EVALUATION OF LIVE TULAREMIA VACCINE PREPARED IN A CHEMICALLY DEFINED MEDIUM. , 1965, Applied microbiology.